Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Fluid-gravity model for the chiral magnetic effect.

Physical review letters

Kalaydzhyan T, Kirsch I.
PMID: 21699286
Phys Rev Lett. 2011 May 27;106(21):211601. doi: 10.1103/PhysRevLett.106.211601. Epub 2011 May 23.

We consider the STU model as a gravity dual of a strongly coupled plasma with multiple anomalous U(1) currents. In the bulk we add additional background gauge fields to include the effects of external electric and magnetic fields on...

Cite
Kalaydzhyan T, Kirsch I. Fluid-gravity model for the chiral magnetic effect. Phys Rev Lett. 2011;106(21):211601doi: 10.1103/PhysRevLett.106.211601.
Kalaydzhyan, T., & Kirsch, I. (2011). Fluid-gravity model for the chiral magnetic effect. Physical review letters, 106(21), 211601. https://doi.org/10.1103/PhysRevLett.106.211601
Kalaydzhyan, Tigran, and Kirsch, Ingo. "Fluid-gravity model for the chiral magnetic effect." Physical review letters vol. 106,21 (2011): 211601. doi: https://doi.org/10.1103/PhysRevLett.106.211601
Kalaydzhyan T, Kirsch I. Fluid-gravity model for the chiral magnetic effect. Phys Rev Lett. 2011 May 27;106(21):211601. doi: 10.1103/PhysRevLett.106.211601. Epub 2011 May 23. PMID: 21699286.
Copy Download .nbib Format: NLM
Treatments for depression: Side-effects, adverse events and health risks.

Journal of affective disorders

Kirsch I, Ness AR, Appleton KM.
PMID: 31437699
J Affect Disord. 2019 Dec 01;259:38-39. doi: 10.1016/j.jad.2019.08.018. Epub 2019 Aug 13.

No abstract available.

Cite
Kirsch I, Ness AR, Appleton KM. Treatments for depression: Side-effects, adverse events and health risks. J Affect Disord. 2019;259:38-39doi: 10.1016/j.jad.2019.08.018.
Kirsch, I., Ness, A. R., & Appleton, K. M. (2019). Treatments for depression: Side-effects, adverse events and health risks. Journal of affective disorders, 25938-39. https://doi.org/10.1016/j.jad.2019.08.018
Kirsch, I, et al. "Treatments for depression: Side-effects, adverse events and health risks." Journal of affective disorders vol. 259 (2019): 38-39. doi: https://doi.org/10.1016/j.jad.2019.08.018
Kirsch I, Ness AR, Appleton KM. Treatments for depression: Side-effects, adverse events and health risks. J Affect Disord. 2019 Dec 01;259:38-39. doi: 10.1016/j.jad.2019.08.018. Epub 2019 Aug 13. PMID: 31437699.
Copy Download .nbib Format: NLM
Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis.

PloS one

Kube T, Hofmann VE, Glombiewski JA, Kirsch I.
PMID: 34077482
PLoS One. 2021 Jun 02;16(6):e0252850. doi: 10.1371/journal.pone.0252850. eCollection 2021.

[This corrects the article DOI: 10.1371/journal.pone.0248367.].

Cite
Kube T, Hofmann VE, Glombiewski JA, et al. Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. PLoS One. 2021;16(6):e0252850doi: 10.1371/journal.pone.0252850.
Kube, T., Hofmann, V. E., Glombiewski, J. A., & Kirsch, I. (2021). Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. PloS one, 16(6), e0252850. https://doi.org/10.1371/journal.pone.0252850
Kube, Tobias, et al. "Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis." PloS one vol. 16,6 (2021): e0252850. doi: https://doi.org/10.1371/journal.pone.0252850
Kube T, Hofmann VE, Glombiewski JA, Kirsch I. Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. PLoS One. 2021 Jun 02;16(6):e0252850. doi: 10.1371/journal.pone.0252850. eCollection 2021. PMID: 34077482; PMCID: PMC8171944.
Copy Download .nbib Format: NLM
Genetic Testing for Cancer Risk Assessment: A Review.

The oncologist

Grogan L, Kirsch IR.
PMID: 10388052
Oncologist. 1997;2(4):208-222.

Both environmental factors and an inherited predisposition influence carcinogenesis. The direct role of inheritance in the development of cancer is evident in familial cancer syndromes. These syndromes predispose to cancer through the inheritance of a mutation in a single...

Cite
Grogan L, Kirsch IR. Genetic Testing for Cancer Risk Assessment: A Review. Oncologist. 1997;2(4):208-222
Grogan, L., & Kirsch, I. R. (1997). Genetic Testing for Cancer Risk Assessment: A Review. The oncologist, 2(4), 208-222.
Grogan, and Kirsch. "Genetic Testing for Cancer Risk Assessment: A Review." The oncologist vol. 2,4 (1997): 208-222.
Grogan L, Kirsch IR. Genetic Testing for Cancer Risk Assessment: A Review. Oncologist. 1997;2(4):208-222. PMID: 10388052.
Copy Download .nbib Format: NLM
Sharing clinical notes, and placebo and nocebo effects: Can documentation affect patient health?.

Journal of health psychology

Blease CR, Delbanco T, Torous J, Ponten M, DesRoches CM, Hagglund M, Walker J, Kirsch I.
PMID: 32772861
J Health Psychol. 2020 Aug 10;1359105320948588. doi: 10.1177/1359105320948588. Epub 2020 Aug 10.

This paper connects findings from the field of placebo studies with research into patients' interactions with their clinician's visit notes, housed in their electronic health records. We propose specific hypotheses about how features of clinicians' written notes might trigger...

Cite
Blease CR, Delbanco T, Torous J, et al. Sharing clinical notes, and placebo and nocebo effects: Can documentation affect patient health?. J Health Psychol. 2020;1359105320948588doi: 10.1177/1359105320948588.
Blease, C. R., Delbanco, T., Torous, J., Ponten, M., DesRoches, C. M., Hagglund, M., Walker, J., & Kirsch, I. (2020). Sharing clinical notes, and placebo and nocebo effects: Can documentation affect patient health?. Journal of health psychology, 1359105320948588. https://doi.org/10.1177/1359105320948588
Blease, Charlotte R, et al. "Sharing clinical notes, and placebo and nocebo effects: Can documentation affect patient health?." Journal of health psychology vol. (2020): 1359105320948588. doi: https://doi.org/10.1177/1359105320948588
Blease CR, Delbanco T, Torous J, Ponten M, DesRoches CM, Hagglund M, Walker J, Kirsch I. Sharing clinical notes, and placebo and nocebo effects: Can documentation affect patient health?. J Health Psychol. 2020 Aug 10;1359105320948588. doi: 10.1177/1359105320948588. Epub 2020 Aug 10. PMID: 32772861.
Copy Download .nbib Format: NLM
Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases.

ERJ open research

Stahl M, Joachim C, Kirsch I, Uselmann T, Yu Y, Alfeis N, Berger C, Minso R, Rudolf I, Stolpe C, Bovermann X, Liboschik L, Steinmetz A, Tennhardt D, Dörfler F, Röhmel J, Unorji-Frank K, Rückes-Nilges C, von Stoutz B, Naehrlich L, Kopp MV, Dittrich AM, Sommerburg O, Mall MA.
PMID: 33263048
ERJ Open Res. 2020 Oct 26;6(4). doi: 10.1183/23120541.00408-2020. eCollection 2020 Oct.

BACKGROUND: Multiple-breath washout (MBW)-derived lung clearance index (LCI) detects early cystic fibrosis (CF) lung disease. LCI was used as an end-point in single- and multicentre settings at highly experienced MBW centres in preschool children. However, multicentre feasibility of MBW...

Cite
Stahl M, Joachim C, Kirsch I, et al. Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases. ERJ Open Res. 2020;6(4)doi: 10.1183/23120541.00408-2020.
Stahl, M., Joachim, C., Kirsch, I., Uselmann, T., Yu, Y., Alfeis, N., Berger, C., Minso, R., Rudolf, I., Stolpe, C., Bovermann, X., Liboschik, L., Steinmetz, A., Tennhardt, D., Dörfler, F., Röhmel, J., Unorji-Frank, K., Rückes-Nilges, C., von Stoutz, B., Naehrlich, L., Kopp, M. V., Dittrich, A. M., Sommerburg, O., & Mall, M. A. (2020). Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases. ERJ open research, 6(4), . https://doi.org/10.1183/23120541.00408-2020
Stahl, Mirjam, et al. "Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases." ERJ open research vol. 6,4 (2020). doi: https://doi.org/10.1183/23120541.00408-2020
Stahl M, Joachim C, Kirsch I, Uselmann T, Yu Y, Alfeis N, Berger C, Minso R, Rudolf I, Stolpe C, Bovermann X, Liboschik L, Steinmetz A, Tennhardt D, Dörfler F, Röhmel J, Unorji-Frank K, Rückes-Nilges C, von Stoutz B, Naehrlich L, Kopp MV, Dittrich AM, Sommerburg O, Mall MA. Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases. ERJ Open Res. 2020 Oct 26;6(4). doi: 10.1183/23120541.00408-2020. eCollection 2020 Oct. PMID: 33263048; PMCID: PMC7682699.
Copy Download .nbib Format: NLM
In-Plane and Out-of-Plane MEMS Piezoresistive Cantilever Sensors for Nanoparticle Mass Detection.

Sensors (Basel, Switzerland)

Setiono A, Bertke M, Nyang'au WO, Xu J, Fahrbach M, Kirsch I, Uhde E, Deutschinger A, Fantner EJ, Schwalb CH, Wasisto HS, Peiner E.
PMID: 31979161
Sensors (Basel). 2020 Jan 22;20(3). doi: 10.3390/s20030618.

In this study, we investigate the performance of two piezoresistive micro-electro-mechanical system (MEMS)-based silicon cantilever sensors for measuring target analytes (i.e., ultrafine particulate matters). We use two different types of cantilevers with geometric dimensions of 1000 × 170 ×...

Cite
Setiono A, Bertke M, Nyang'au WO, et al. In-Plane and Out-of-Plane MEMS Piezoresistive Cantilever Sensors for Nanoparticle Mass Detection. Sensors (Basel). 2020;20(3)doi: 10.3390/s20030618.
Setiono, A., Bertke, M., Nyang'au, W. O., Xu, J., Fahrbach, M., Kirsch, I., Uhde, E., Deutschinger, A., Fantner, E. J., Schwalb, C. H., Wasisto, H. S., & Peiner, E. (2020). In-Plane and Out-of-Plane MEMS Piezoresistive Cantilever Sensors for Nanoparticle Mass Detection. Sensors (Basel, Switzerland), 20(3), . https://doi.org/10.3390/s20030618
Setiono, Andi, et al. "In-Plane and Out-of-Plane MEMS Piezoresistive Cantilever Sensors for Nanoparticle Mass Detection." Sensors (Basel, Switzerland) vol. 20,3 (2020). doi: https://doi.org/10.3390/s20030618
Setiono A, Bertke M, Nyang'au WO, Xu J, Fahrbach M, Kirsch I, Uhde E, Deutschinger A, Fantner EJ, Schwalb CH, Wasisto HS, Peiner E. In-Plane and Out-of-Plane MEMS Piezoresistive Cantilever Sensors for Nanoparticle Mass Detection. Sensors (Basel). 2020 Jan 22;20(3). doi: 10.3390/s20030618. PMID: 31979161; PMCID: PMC7038349.
Copy Download .nbib Format: NLM
[Case control studies and their role in the study of risk factors].

Zeitschrift fur arztliche Fortbildung

Kreuz B, Kirsch I.
PMID: 7281768
Z Arztl Fortbild (Jena). 1981 Mar 15;75(6):288-92.

No abstract available.

Cite
Kreuz B, Kirsch I. Uber Fall-Kontroll-Studien und ihre Rolle bei der Erzeugung von Risikofaktoren. [Case control studies and their role in the study of risk factors]. Z Arztl Fortbild (Jena). 1981;75(6):288-92
Kreuz, B., & Kirsch, I. (1981). Uber Fall-Kontroll-Studien und ihre Rolle bei der Erzeugung von Risikofaktoren. [Case control studies and their role in the study of risk factors]. Zeitschrift fur arztliche Fortbildung, 75(6), 288-92.
Kreuz, B, and Kirsch, I. "Uber Fall-Kontroll-Studien und ihre Rolle bei der Erzeugung von Risikofaktoren." [Case control studies and their role in the study of risk factors]. Zeitschrift fur arztliche Fortbildung vol. 75,6 (1981): 288-92.
Kreuz B, Kirsch I. Uber Fall-Kontroll-Studien und ihre Rolle bei der Erzeugung von Risikofaktoren. [Case control studies and their role in the study of risk factors]. Z Arztl Fortbild (Jena). 1981 Mar 15;75(6):288-92. German. PMID: 7281768.
Copy Download .nbib Format: NLM
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.

Clinical cancer research : an official journal of the American Association for Cancer Research

Anderson KC, Auclair D, Adam SJ, Agarwal A, Anderson M, Avet-Loiseau H, Bustoros M, Chapman J, Connors DE, Dash A, Di Bacco A, Du L, Facon T, Flores-Montero J, Gay F, Ghobrial IM, Gormley NJ, Gupta I, Higley H, Hillengass J, Kanapuru B, Kazandjian D, Kelloff GJ, Kirsch IR, Kremer BE, Landgren O, Lightbody ED, Lomas OC, Lonial S, Mateos MV, Montes de Oca R, Mukundan L, Munshi NC, O'Donnell EK, Orfao A, Paiva B, Patel R, Pugh TJ, Ramasamy K, Ray J, Roshal M, Ross JA, Sigman CC, Thoren KL, Trudel S, Ulaner GA, Valente N, Weiss BM, Zamagni E, Kumar SK.
PMID: 34321279
Clin Cancer Res. 2021 Jul 28; doi: 10.1158/1078-0432.CCR-21-1059. Epub 2021 Jul 28.

The development of novel agents has transformed the treatment paradigm for multiple myeloma (MM), with minimal residual disease (MRD) negativity now achievable across the entire disease spectrum. Bone marrow-based technologies to assess MRD, including approaches using next-generation flow and...

Cite
Anderson KC, Auclair D, Adam SJ, et al. Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-1059.
Anderson, K. C., Auclair, D., Adam, S. J., Agarwal, A., Anderson, M., Avet-Loiseau, H., Bustoros, M., Chapman, J., Connors, D. E., Dash, A., Di Bacco, A., Du, L., Facon, T., Flores-Montero, J., Gay, F., Ghobrial, I. M., Gormley, N. J., Gupta, I., Higley, H., Hillengass, J., Kanapuru, B., Kazandjian, D., Kelloff, G. J., Kirsch, I. R., Kremer, B. E., Landgren, O., Lightbody, E. D., Lomas, O. C., Lonial, S., Mateos, M. V., Montes de Oca, R., Mukundan, L., Munshi, N. C., O'Donnell, E. K., Orfao, A., Paiva, B., Patel, R., Pugh, T. J., Ramasamy, K., Ray, J., Roshal, M., Ross, J. A., Sigman, C. C., Thoren, K. L., Trudel, S., Ulaner, G. A., Valente, N., Weiss, B. M., Zamagni, E., & Kumar, S. K. (2021). Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-1059
Anderson, Kenneth C, et al. "Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-1059
Anderson KC, Auclair D, Adam SJ, Agarwal A, Anderson M, Avet-Loiseau H, Bustoros M, Chapman J, Connors DE, Dash A, Di Bacco A, Du L, Facon T, Flores-Montero J, Gay F, Ghobrial IM, Gormley NJ, Gupta I, Higley H, Hillengass J, Kanapuru B, Kazandjian D, Kelloff GJ, Kirsch IR, Kremer BE, Landgren O, Lightbody ED, Lomas OC, Lonial S, Mateos MV, Montes de Oca R, Mukundan L, Munshi NC, O'Donnell EK, Orfao A, Paiva B, Patel R, Pugh TJ, Ramasamy K, Ray J, Roshal M, Ross JA, Sigman CC, Thoren KL, Trudel S, Ulaner GA, Valente N, Weiss BM, Zamagni E, Kumar SK. Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clin Cancer Res. 2021 Jul 28; doi: 10.1158/1078-0432.CCR-21-1059. Epub 2021 Jul 28. PMID: 34321279.
Copy Download .nbib Format: NLM
Preparing for an epidemic of limited health literacy: weathering the perfect storm.

Journal of general internal medicine

Parker RM, Wolf MS, Kirsch I.
PMID: 18452047
J Gen Intern Med. 2008 Aug;23(8):1273-6. doi: 10.1007/s11606-008-0621-1. Epub 2008 May 02.

Empirical data collected over the past two decades have demonstrated strong links between low literacy skills and poor health outcomes, including mortality. Recently, the Educational Testing Service released a relevant report predicting that our nation is at great risk...

Cite
Parker RM, Wolf MS, Kirsch I. Preparing for an epidemic of limited health literacy: weathering the perfect storm. J Gen Intern Med. 2008;23(8):1273-6doi: 10.1007/s11606-008-0621-1.
Parker, R. M., Wolf, M. S., & Kirsch, I. (2008). Preparing for an epidemic of limited health literacy: weathering the perfect storm. Journal of general internal medicine, 23(8), 1273-6. https://doi.org/10.1007/s11606-008-0621-1
Parker, Ruth M, et al. "Preparing for an epidemic of limited health literacy: weathering the perfect storm." Journal of general internal medicine vol. 23,8 (2008): 1273-6. doi: https://doi.org/10.1007/s11606-008-0621-1
Parker RM, Wolf MS, Kirsch I. Preparing for an epidemic of limited health literacy: weathering the perfect storm. J Gen Intern Med. 2008 Aug;23(8):1273-6. doi: 10.1007/s11606-008-0621-1. Epub 2008 May 02. PMID: 18452047; PMCID: PMC2517979.
Copy Download .nbib Format: NLM
Challenging received wisdom: antidepressants and the placebo effect.

McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students

Kirsch I.
PMID: 19148327
Mcgill J Med. 2008 Jul;11(2):219-22.

This article explores the reaction when an article challenging received wisdom is published and covered extensively by the media (1). The article in question was a meta-analysis of antidepressant clinical trials indicating that for most patients, difference between drug...

Cite
Kirsch I. Challenging received wisdom: antidepressants and the placebo effect. Mcgill J Med. 2008;11(2):219-22
Kirsch, I. (2008). Challenging received wisdom: antidepressants and the placebo effect. McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students, 11(2), 219-22.
Kirsch, Irving. "Challenging received wisdom: antidepressants and the placebo effect." McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students vol. 11,2 (2008): 219-22.
Kirsch I. Challenging received wisdom: antidepressants and the placebo effect. Mcgill J Med. 2008 Jul;11(2):219-22. PMID: 19148327; PMCID: PMC2582668.
Copy Download .nbib Format: NLM
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.

Journal for immunotherapy of cancer

Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, Lyerly HK, Maecker H, Marabelle A, Melenhorst J, Miller J, Melero I, Odunsi K, Palucka K, Peoples G, Ribas A, Robins H, Robinson W, Serafini T, Sondel P, Vivier E, Weber J, Wolchok J, Zitvogel L, Disis ML, Cheever MA.
PMID: 26981245
J Immunother Cancer. 2016 Mar 15;4:15. doi: 10.1186/s40425-016-0118-0. eCollection 2016.

The efficacy of PD-1/PD-L1 targeted therapies in addition to anti-CTLA-4 solidifies immunotherapy as a modality to add to the anticancer arsenal. Despite raising the bar of clinical efficacy, immunologically targeted agents raise new challenges to conventional drug development paradigms...

Cite
Kohrt HE, Tumeh PC, Benson D, et al. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. J Immunother Cancer. 2016;4:15doi: 10.1186/s40425-016-0118-0.
Kohrt, H. E., Tumeh, P. C., Benson, D., Bhardwaj, N., Brody, J., Formenti, S., Fox, B. A., Galon, J., June, C. H., Kalos, M., Kirsch, I., Kleen, T., Kroemer, G., Lanier, L., Levy, R., Lyerly, H. K., Maecker, H., Marabelle, A., Melenhorst, J., Miller, J., Melero, I., Odunsi, K., Palucka, K., Peoples, G., Ribas, A., Robins, H., Robinson, W., Serafini, T., Sondel, P., Vivier, E., Weber, J., Wolchok, J., Zitvogel, L., Disis, M. L., Cheever, M. A. (2016). Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal for immunotherapy of cancer, 415. https://doi.org/10.1186/s40425-016-0118-0
Kohrt, Holbrook E, et al. "Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials." Journal for immunotherapy of cancer vol. 4 (2016): 15. doi: https://doi.org/10.1186/s40425-016-0118-0
Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, Lyerly HK, Maecker H, Marabelle A, Melenhorst J, Miller J, Melero I, Odunsi K, Palucka K, Peoples G, Ribas A, Robins H, Robinson W, Serafini T, Sondel P, Vivier E, Weber J, Wolchok J, Zitvogel L, Disis ML, Cheever MA. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. J Immunother Cancer. 2016 Mar 15;4:15. doi: 10.1186/s40425-016-0118-0. eCollection 2016. PMID: 26981245; PMCID: PMC4791805.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries